Pursuant to Regulation 47 and 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, in connection with, the 33rd Annual General Meeting of Norris Medicines, to be held on Monday 30th September, 2024 at 12.00 PM through Video Conferencing /Other Audio-Visual means, Norris Medicines has attached copies of newspaper advertisement published on Thursday, 05th September, 2024 as Pre-Dispatch of Notice of AGM and advertisement published on Tuesday, 10th September, 2024 as Post-Dispatch of Notice of AGM & Annual Report for the Financial Year 2023-2024 to the shareholders, E-Voting Information and Notice of Book Closure.
The above information is a part of company’s filings submitted to BSE.
